STOCK TITAN

INTERNATIONAL BAT MET (IBATF) Financials

IBATF
FY2026 annual
Revenue $164K -81.2% YoY
Net Income $122K n/m YoY
EPS (Diluted) $0.00 n/m YoY
Free Cash Flow -$10.1M n/m YoY
Market Cap $24.4M as of Oct 23, 2026
Price / Sales 149x on $164K revenue, FY2026
Price / Earnings 200x on $122K net income, FY2026
Price / Book 0.9x on $28.6M equity, Q1 FY2027

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 23, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2027, ended Jun 30, 2026 Reported Currency USD FYE March

Newest figures come from the 10-Q for Q1 FY2027, filed Aug 12, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the IBATF SEC filings page.

INTERNATIONAL BAT MET (IBATF) reported $164K in revenue for fiscal year 2026, down 81.2% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 2 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI IBATF FY2026

The business remains asset-heavy and cash-consuming: FY2026 revenue was $164K against operating cash flow of -$9.67M.

FY2026 produced net income of $122K but operating cash flow of -$9.67M; that mismatch means reported profitability did not translate into cash. Revenue fell 81.2%, yet SG&A was $8.46M, leaving overhead out of proportion to the smaller sales base.

The balance sheet is lightly debt-funded: long-term debt was $44K while liabilities were 28.7% of assets. A 7.6x current ratio and liquidity equal to 11.4 months of the latest annual reported outflow indicate short-term flexibility, but do not erase the cash-generation gap.

Capital expenditures equaled 244.5% of revenue, while free cash flow was -$10.07M; the business needed more than sales to fund operations and reinvestment. Financing cash flow provided $8.52M, down 65.2%, showing that FY2026 cash needs were partly met outside operations.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

INTERNATIONAL BAT MET does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Altman Z-Score Distress
-0.94

INTERNATIONAL BAT MET scores -0.94, below the 1.81 distress threshold. The score is pulled down most by an accumulated deficit of $39.4M against total assets of $39.8M. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral
4/9

INTERNATIONAL BAT MET passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality No Cash Backing
N/A

INTERNATIONAL BAT MET reported $122K of net income while operations used $9.7M of cash. The ratio between the two is outside the range this page publishes as a per-dollar figure, so both figures are given instead.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$120K
YoY+1614.3%

INTERNATIONAL BAT MET generated $120K in revenue in Q1 2027. This represents an increase of 1614.3% from the same quarter a year earlier.

EBITDA
-$2.4M
YoYn/m

INTERNATIONAL BAT MET's EBITDA was -$2.4M in Q1 2027, measuring earnings before interest, taxes, depreciation, and amortization. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.

Net Income
-$28K
YoY-101.7%

INTERNATIONAL BAT MET reported a net loss of $28K in Q1 2027. This represents a decrease of 101.7% from the same quarter a year earlier.

EPS (Diluted)
$0.00
YoY-100.0%
QoQn/m

INTERNATIONAL BAT MET earned $0.00 per diluted share (EPS) in Q1 2027. This represents a decrease of 100.0% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Cash & Balance Sheet

Free Cash Flow
-$2.3M
YoYn/m
QoQn/m

INTERNATIONAL BAT MET recorded an outflow of $2.3M in free cash flow in Q1 2027, representing a cash shortfall after capex. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Cash & Debt
$9.4M
YoY+34.4%
QoQ+2.8%

INTERNATIONAL BAT MET held $9.4M in cash against $20K in long-term debt as of Q1 2027.

Shares Outstanding
379M
QoQ+0.4%

INTERNATIONAL BAT MET had 379M shares outstanding in Q1 2027. Against the prior quarter it is up 0.4%.

Dividends Per Share

Not reported for Q1 2027.

Margins & Returns

Gross Margin
97.5%
YoY+11.8pp

INTERNATIONAL BAT MET's gross margin was 97.5% in Q1 2027, indicating the percentage of revenue retained after direct costs. This is up 11.8 percentage points from the same quarter a year earlier.

Net Margin
-23.3%

INTERNATIONAL BAT MET's net profit margin was -23.3% in Q1 2027, showing the share of revenue converted to profit. No change is given against Q1 2026: its reported ratio is above 100.0% of revenue, so it does not read as a share of revenue.

Return on Equity
-0.1%
YoY-6.1pp

INTERNATIONAL BAT MET's quarterly ROE was -0.1% in Q1 2027: one quarter's net income over shareholder equity, not annualized. This is down 6.1 percentage points from the same quarter a year earlier.

Operating Margin

Not shown for Q1 2027: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Capital Allocation

Capital Expenditures
$2K
YoY-99.4%
QoQ-94.1%

INTERNATIONAL BAT MET invested $2K in capex in Q1 2027, funding long-term assets and infrastructure. This represents a decrease of 99.4% from the same quarter a year earlier. Against the prior quarter it is down 94.1%.

R&D Spending

Not reported for Q1 2027.

Share Buybacks

Not reported for Q1 2027.

IBATF Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

IBATF quarterly income statement
MetricQ1'2710-QQ4'2610-QQ3'2610-QQ1'2610-QQ4'2510-KQ3'2510-Q
Revenue$120K+1614.3%N/A$30K$7KN/AN/A
Cost of Revenue$3K+200.0%N/A$22Kn/m$1KN/A$0
Gross Profit$117K+1850.0%N/A$8Kn/m$6KN/A-$4K
SG&A Expenses$1.8M-19.1%N/A$1.8M-14.2%$2.3MN/A$2.1M
Operating Income-$2.9Mn/mN/A-$3.0Mn/m-$3.6MN/A-$3.3M
EBITDA-$2.4Mn/mN/A-$2.5Mn/m-$3.1MN/A-$2.9M
Income Tax$0n/mN/AN/A$0N/AN/A
Net Income-$28K-101.7%N/A$754Kn/m$1.7MN/A-$10.9M
EPS (Basic)$0.00-100.0%-$0.02-300.0%$0.00n/m$0.01$0.01-$0.04
EPS (Diluted)$0.00-100.0%-$0.02-300.0%$0.00n/m$0.01$0.01-$0.04
Diluted Shares (Avg)362M+30.5%N/A311M+27.9%277MN/A243M

Not reported in any period shown, so not listed: R&D Expenses, Interest Expense.

IBATF Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

IBATF quarterly balance sheet
MetricQ1'2710-QQ4'2610-QQ3'2610-QQ1'2610-QQ4'2510-KQ3'2510-Q
Total Assets$39.2M$39.8M-10.6%$40.9MN/A$44.5MN/A
Current Assets$10.8M$10.6M-15.5%$11.0MN/A$12.5MN/A
Cash & Equivalents$9.4M+34.4%$9.2M-14.4%$9.1M+68.0%$7.0M$10.7M$5.4M
Short-Term Investments$0n/m$0n/m$0n/m$0$0$0
InventoryN/A$1.1M0.0%$1.1MN/A$1.1MN/A
Accounts Receivable$55K$70K-84.3%$471KN/A$447KN/A
Long-Term Investments$0n/m$0n/m$0n/m$0$0$0
Total Liabilities$10.6M$11.4M-36.3%$7.6MN/A$17.9MN/A
Current Liabilities$776K$1.4M-46.6%$1.4MN/A$2.6MN/A
Non-Current Liabilities$9.8M$10.0M-34.5%$6.2MN/A$15.3MN/A
Long-Term Debt$20K$44K-69.2%$70KN/A$143KN/A
Total Equity$28.6M+2.3%$28.4M+6.7%$33.4M+26.4%$27.9M$26.6M$26.4M
Retained Earnings-$39.5M-$39.4Mn/m-$34.1MN/A-$39.6MN/A

Not reported in any period shown, so not listed: Goodwill.

IBATF Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

IBATF quarterly cash flow statement
MetricQ1'2710-QQ4'2610-QQ3'2610-QQ1'2610-QQ4'2510-KQ3'2510-Q
Operating Cash Flow-$2.3Mn/m-$1.7Mn/mN/A-$3.3M-$2.4MN/A
Depreciation & Amortization$500K0.0%$500K-16.7%$500K+25.0%$500K$600K$400K
Stock-Based Compensation$369Kn/mN/A$405K-7.3%-$276KN/A$437K
Capital Expenditures$2K-99.4%$34K-76.7%N/A$351K$146KN/A
Free Cash Flow-$2.3Mn/m-$1.8Mn/mN/A-$3.7M-$2.5MN/A
Investing Cash Flow-$2Kn/m-$34Kn/mN/A-$351K-$146KN/A
Financing Cash Flow$2.6Mn/m$1.8M-76.5%N/A-$27K$7.8MN/A

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

IBATF Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

IBATF quarterly financial ratios
MetricQ1'2710-QQ4'2610-QQ3'2610-QQ1'2610-QQ4'2510-KQ3'2510-Q
Gross Margin97.5%+11.8ppN/A26.7%85.7%N/AN/A
Operating Margin-2422.5%N/A-10046.7%-51971.4%N/AN/A
Net Margin-23.3%N/A2513.3%24114.3%N/AN/A
Return on Equity-0.1%-6.1ppN/A2.3%+43.6pp6.0%N/A-41.3%
Return on Assets-0.1%N/A1.8%N/AN/AN/A
Current Ratio13.927.64+2.8x7.84N/A4.83N/A
Debt-to-Equity0.000.000.0x0.00N/A0.01N/A
Liabilities-to-Equity0.370.40-0.3x0.23N/A0.67N/A
Asset Turnover0.00N/A0.00N/AN/AN/A
FCF Margin-1952.5%N/AN/A-52642.9%N/AN/A

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.

Frequently Asked Questions

What is INTERNATIONAL BAT MET's annual revenue?

INTERNATIONAL BAT MET (IBATF) reported $164K in total revenue for fiscal year 2026. This represents a -81.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is INTERNATIONAL BAT MET's revenue growing?

INTERNATIONAL BAT MET (IBATF) revenue declined by 81.2% year-over-year, from $871K to $164K in fiscal year 2026.

Is INTERNATIONAL BAT MET profitable?

Yes, INTERNATIONAL BAT MET (IBATF) reported a net income of $122K in fiscal year 2026, with a net profit margin of 74.4%.

INTERNATIONAL BAT MET (IBATF) reported diluted earnings per share of $0.00 for fiscal year 2026. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

INTERNATIONAL BAT MET (IBATF) had EBITDA of -$11.5M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2026, INTERNATIONAL BAT MET (IBATF) had $9.2M in cash and equivalents against $44K in long-term debt.

INTERNATIONAL BAT MET (IBATF) had a gross margin of 79.3% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

INTERNATIONAL BAT MET (IBATF) had a net profit margin of 74.4% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

INTERNATIONAL BAT MET (IBATF) has a return on equity of 0.4% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

INTERNATIONAL BAT MET (IBATF) recorded an outflow of $10.1M in free cash flow during fiscal year 2026. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

INTERNATIONAL BAT MET (IBATF) recorded an outflow of $9.7M in operating cash flow during fiscal year 2026, representing cash used by core business activities.

INTERNATIONAL BAT MET (IBATF) had $39.8M in total assets as of fiscal year 2026, including both current and long-term assets.

INTERNATIONAL BAT MET (IBATF) invested $401K in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

INTERNATIONAL BAT MET (IBATF) had 378M shares outstanding as of fiscal year 2026.

INTERNATIONAL BAT MET (IBATF) had a current ratio of 7.64 as of fiscal year 2026, which is generally considered healthy.

INTERNATIONAL BAT MET (IBATF) had a debt-to-equity ratio of 0.00 as of fiscal year 2026. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.

INTERNATIONAL BAT MET (IBATF) had a liabilities-to-equity ratio of 0.40 as of fiscal year 2026, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.

INTERNATIONAL BAT MET (IBATF) had a return on assets of 0.3% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

INTERNATIONAL BAT MET (IBATF) trades at 200x earnings, its market capitalization divided by $122K net income, FY2026. The market capitalization is $24.4M as of Oct 23, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

INTERNATIONAL BAT MET (IBATF) trades at 149x sales, its market capitalization divided by $164K revenue, FY2026. The market capitalization is $24.4M as of Oct 23, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

At the end of fiscal year 2026, INTERNATIONAL BAT MET (IBATF) held $9.2M in cash, cash equivalents and investments, and reported an operating cash outflow of $9.7M over that year. Dividing the one by the other, the reported balance equals about 11 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

INTERNATIONAL BAT MET (IBATF) has an Altman Z-Score of -0.94, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

INTERNATIONAL BAT MET (IBATF) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

INTERNATIONAL BAT MET (IBATF) reported $122K of net income while operations used $9.7M of cash. The ratio between the two is outside the range this page publishes as a per-dollar figure, so both figures are given instead. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Back to top